1-4 of 4
Michael J Dugan, MD
Close
Sort by
Journal Articles

Donor Lymphocyte Infusions Used to Treat Mixed Chimerism in Relapsed and Non-Relapsed Patient Populations after Allogeneic Transplant for Hematologic Malignancies Are Associated with High 5-Year Survival If Persistent Full Donor Chimerism Is Obtained

Lauren E Caldemeyer, BA, Luke P Akard, MD, John R Edwards, MD, Michael J Dugan, MD
Journal: Blood
Blood (2016) 128 (22): 3443.
https://doi.org/10.1182/blood.V128.22.3443.3443
Published: 2016
Journal Articles

A Subgroup Analysis of Patients Undergoing Autologous and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Deflect-1: A Double-Blind, Randomized Study of Fidaxomicin Vs. Placebo for Prophylaxis Against C. Difficile Infection

Michael J Dugan, MD, Drew Winston, MD, Michele I Morris, MD, James E Williams, MD, Natasha Broyde, MS, Pamela Sears, PhD
Journal: Blood
Blood (2015) 126 (23): 390.
https://doi.org/10.1182/blood.V126.23.390.390
Published: 2015
Journal Articles

The Effect of Physical Conditions on the Transportation of Peripheral Blood Progenitor (PBPC) Products.

Jan Jansen, MD, PhD., Pamela L Nolan, MT(ASCP), Margaret I Reeves, BS, Luke Paul Akard, MD, James M. Thompson, DO, Michael J Dugan, MD, Susan G Hanks, MS
Journal: Blood
Blood (2008) 112 (11): 2315.
https://doi.org/10.1182/blood.V112.11.2315.2315
Published: 2008
Journal Articles

Treatment with AMD3100 in Multiple Myeloma or Non-Hodgkin’s Lymphoma Patients to Increase the Number of Peripheral Blood Stem Cells When Given with a Mobilizing Regimen of Chemotherapy and G-CSF.

Michael J. Dugan, MD, Luke P. Akard, MD, James M. Thompson, DO, Auayporn Nademanee, MD, Richard T. Maziarz, MD, William I. Bensinger, MD, Jane Liesveld, MD, Karin Badel, Christine Dehner, Colleen Gibney, Gary Calandra, Jan Jansen, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2860.
https://doi.org/10.1182/blood.V104.11.2860.2860
Published: 2004